Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

Beyond the Label

Ensuring That Drug Benefits Outweigh Risks in the Food and Drug Administration's Risk Evaluation and Mitigation Strategy Program

Epstein, Michael S. MD, FACG; Shah, Eric D. MD; Deepak, Parakkal MD, MBBS, MS; Kushnir, Vladimir M. MD

American Journal of Gastroenterology: July 2019 - Volume 114 - Issue 7 - p 1017–1019
doi: 10.14309/ajg.0000000000000215

Correspondence: Michael S. Epstein, MD, FACG. E-mail:

Received December 11, 2018

Accepted March 04, 2019

© The American College of Gastroenterology 2019. All Rights Reserved.
You currently do not have access to this article

To access this article:

Note: If your society membership provides full-access, you may need to login on your society website